Ewa, LLC Abb Vie Inc. Transaction History

Ewa, LLC

$223 Billion
Q1 2024

A detailed history of Ewa, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ewa, LLC holds 1,536 shares of ABBV stock, worth $254,914. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,536

Holding current value

$254,914

% of portfolio

0.11%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $245,483 - $279,705	1,536 New	1,536 $247 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

Vanguard Group Inc Valley Forge, PA

170M
Shares

$28.3 Billion
0.62% of portfolio
Black Rock Inc. New York, NY

143M
Shares

$23.7 Billion
0.61% of portfolio
State Street Corp Boston, MA

78M
Shares

$12.9 Billion
0.64% of portfolio
Jpmorgan Chase & CO New York, NY

51.3M
Shares

$8.51 Billion
0.85% of portfolio
Capital International Investors Los Angeles, CA

48.1M
Shares

$7.98 Billion
1.81% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.

Account